Arch Therapeutics, Inc. ARTH Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Arch Therapeutics, Inc. ARTH Company Overview 

Stock Message Board http://investorshangout.com/search?q=ARTH&...mp;yt1=Go!

Arch Therapeutics, Inc. ARTH Current Price and Quotes
Last Price 0.383
Previous Close 0.40 Open 0.40
Daily Range 0.4075 - 0.38 52wk Range 1.36 - 0.01
Volume 163,511 Dividend N/A
Average Vol (3m) 1,294,551 Yield N/A
Arch Therapeutics, Inc. ARTH
Company Information

One Broadway
14th Floor
Cambridge, MA 02142

Website: http://www.almahautoparts.com
Phone: 617-475-5254
Email: almahinc@hotmail.com

Arch Therapeutics, Inc. ARTH
Arch Therapeutics, Inc. ARTH
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001537561
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 5531 - Auto and home supply stores
Business Status Development Stage Company a/o Feb 24, 2012
Incorporated In: NV, USA
Year of Inc. 2009
Employees 0 a/o Feb 24, 2012
Company Officers/Contacts

Terrence W. Norchi President, CEO
William M. Cotter COO
Alan T. Barber CFO
Company Directors

Avtar Dhillon Chairman
Terrence W. Norchi
Arthur Rosenthal
Company Notes

Formerly=Almah Inc until 6-2013
Service Providers

Auditor/Accountant
Moody, Famiglietti, & Andronico
1 Highwood Drive
Tewksbury, MA, 01876
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Arch Therapeutics, Inc. ARTH
ARTH Security Details

Share Structure

Market Value1 $22,652,626 a/o Sep 12, 2013
Shares Outstanding 59,145,237 a/o Aug 13, 2013
Float Not Available
Authorized Shares 75,000,000 a/o Mar 31, 2012
Par Value  0.001
Shareholders

Shareholders of Record 30 a/o Dec 31, 2012
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) May 28, 2013 May 24, 2013 May 24, 2013
Security Notes

Capital Change=shs increased by 11 for 1 split. Ex-date=05/28/2013. Rec date=05/24/2013. Pay date=05/24/2013.
Short Selling Data

Short Interest 518,037 (-14.49%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Empire Stock Transfer Inc.

Arch Therapeutics, Inc. ARTH Recent News

Sept 3, 2013 Arch Therapeutics Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
Aug 6, 2013 Arch Therapeutics Announces Plans for Upcoming Activities
Jul 30, 2013 Arch Therapeutics Reports on Current Activities
Jul 25, 2013 OTC Daily Alert Stock Watch
Jul 23, 2013 Arch Therapeutics Co-Founder Dr. Ellis-Behnke Speaks at 6th Annual CLINAM Nanomedicine Summit in Basel, Switzerland
Jul 16, 2013 Arch Therapeutics Co-Founder Rutledge Ellis-Behnke Delivers Keynote at Nanomaterials Technology Transfer Conference in Corfu, Greece
Jul 16, 2013 ARTH, XUII, AAMRQ and SCRC added to OTC Active Stock Watch List at GSR
Jul 11, 2013 BIZM, ARTH, AAMRQ and SGLB added to Active OTC Watch List at EPR
Jul 9, 2013 BestOTC Daily Stock Watch: Cleantech Transit Inc.(OTCMKTS:CLNO) and Arch Therapeutics, Inc. (OTCBB:ARTH)
Jul 8, 2013 Arch Therapeutics Appoints Senior Management Team Members

1
2
next >

Arch Therapeutics, Inc. ARTH Financials
Period Ending Sep 30, 2012 Sep 30, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses

Research and Development - -
Sales, General and Admin. 37 5
Non-Recurring Items - -
Other - -
Operating Income (37) (5)
Income From Continuing Operations

Add'l Income/Expense Items - -
Earnings Before Interest and Tax (37) (5)
Interest Expense - -
Earnings Before Tax (37) (5)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (37) (5)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (37) (5)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (37) (5)

ARTH Arch Therapeutics, Inc. Research DD Guide

ARTH Arch Therapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=ARTH&...mp;yt0=Go!
ARTH Arch Therapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/ARTH/quote
ARTH Arch Therapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/ARTH/chart
ARTH Arch Therapeutics, Inc. Company Info http://www.otcmarkets.com/stock/ARTH/company-info
ARTH Arch Therapeutics, Inc. Recent News http://www.otcmarkets.com/stock/ARTH/news
ARTH Arch Therapeutics, Inc. Financials http://www.otcmarkets.com/stock/ARTH/financials
ARTH Arch Therapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/ARTH/filings
ARTH Arch Therapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/ARTH/short-sales
ARTH Arch Therapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/ARTH/insider-transactions
ARTH Arch Therapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/ARTH/research
ARTH Arch Therapeutics, Inc. Summary http://finance.yahoo.com/q?s=ARTH
ARTH Arch Therapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=ARTH+Historical+Prices
ARTH Arch Therapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=ARTH
ARTH Arch Therapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=ARTH+Basic+Chart
ARTH Arch Therapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ARTH+Basic+Tech.+Analysis
ARTH Arch Therapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=ARTH+Headlines
ARTH Arch Therapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=ARTH+Press+Releases
ARTH Arch Therapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=ARTH+Profile
ARTH Arch Therapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=ARTH+Key+Statistics
ARTH Arch Therapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=ARTH+Industry
ARTH Arch Therapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=ARTH+Major+Holders
ARTH Arch Therapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=ARTH+Insider+Transactions
ARTH Arch Therapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=ARTH+Insider+Roster
ARTH Arch Therapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=ARTH
ARTH Arch Therapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=ARTH
ARTH Arch Therapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=ARTH+Cash+Flow&annual
ARTH Arch Therapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/ARTH
ARTH Arch Therapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/ARTH
ARTH Arch Therapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/ARTH:US
ARTH Arch Therapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=ARTH
ARTH Arch Therapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=ARTH
ARTH Arch Therapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/ARTH
ARTH Arch Therapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=ARTH
ARTH Arch Therapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/ARTH/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 70

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 11

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 30

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 165

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 121

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 39

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 275

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Matt Hougan Shares Insights on Bitcoin's Potential Surge

Updated Category News Views 165

Understanding Bitcoin's Growth Potential Matt Hougan, the Chief Investment Officer at Bitwise, sheds light on the driving forces behind the burgeoning interest in Bitcoin. He emphasizes concerns over the decline of fiat currencies and noteworthy inflows into Bitcoin ETFs as the catalysts propelling Bitcoin's journey towards new heights. This surge towards potential record...

Continue Reading
Empowering Futures: Access Bank's Commitment to Education

Updated Category News Views 174

Support for Educational Development In recent years, The Access Bank UK Ltd has made significant strides in supporting educational initiatives aimed at transforming lives. This commitment is exemplified by the annual Polo Cup event that they host in collaboration with UNICEF and Fifth Chukker. The Access Bank Cup has become more than just a sporting affair; it is a beacon...

Continue Reading
Gary Brecka's Event Redefines Longevity's Future in L.A.

Updated Category News Views 46

Exploring Longevity: A Day Like No Other Alright, picture this: a convergence of wellness diehards, human performance buffs, and curious minds, all filing into the Peacock Theater in Los Angeles. It's August 16th and they're here for Gary Brecka LIVE. This is no run-of-the-mill wellness seminar; it's an exclusive deep dive into the world of longevity hosted by Sequel...

Continue Reading
Ultragenyx Pharmaceutical and Others Face Challenges in Ratings

Updated Category News Views 164

Stock Market Overview This morning, U.S. stock futures indicated a downward trend, with the Dow futures decreasing by about 100 points. Given the numerous fluctuations in the market recently, this drop is indicative of the challenges many companies are facing. Ultragenyx Pharmaceutical Inc Performance Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have sharply...

Continue Reading
Netflix's Future: Overcoming Slower Subscriber Growth Strategies

Updated Category News Views 185

Analyzing Netflix's Subscription Growth and Future Strategies Netflix, a leading name in streaming services, is facing a potential slowdown in subscriber additions. Analysts suggest that the streaming giant might experience its most modest subscriber growth in the past six quarters as the gains from its recent password-sharing crackdown start to wane. With this shifting...

Continue Reading